A research report released this month by Wall Street securitiesfirm Morgan Stanley reduced income and sales growth projectionsfor radiology ultrasound leader Acuson. Despite market sluggishness,however, the vendor maintains a bottom line that most
A research report released this month by Wall Street securitiesfirm Morgan Stanley reduced income and sales growth projectionsfor radiology ultrasound leader Acuson. Despite market sluggishness,however, the vendor maintains a bottom line that most companieswould envy.
"Based on conversations with management, competitors,physicians and hospital administrators, it seems clear that 1992may be a difficult year in the ultrasound market," said analystPaul A. Brooke. "Share gains will probably be more difficultas Acuson's competition becomes more desperate and hospitals remainuncertain about their capital spending capacities."
Morgan Stanley reiterated its buy recommendation for Acusonstock, noted Robert J. Gallagher, Acuson CFO. Annual revenue growthprojections over the next three years were cut from 25% to 20%,which remains robust.
Increased R&D expenditures, however, should result in adrop in income growth for the company from 20% to slightly over10% in 1992, the report said. Income growth is projected to returnto the 20% level in 1993 and 1994 (see graph).
"This (report) reflects not only the higher commitmentto research and development that we intend to implement in thecoming years, but also the current market environment, which hasbeen in place for some time," Gallagher said.
Medical equipment customers, like most consumers, are hesitantto spend money as the economic recession stretches out, said SamuelH. Maslak, president and CEO. As a relatively inexpensive andversatile medical imaging modality, however, ultrasound is wellpositioned to maintain sales growth.
"As long as the recession is in place, the rate of growthof spending in the ultrasound marketplace will be slower,"Maslak told SCAN. "But I don't think there is any decreasein spending this year over last year, and I don't anticipate anydecrease in expenditures next year."
A 20% growth rate during a recession would be considered spectacularin most industries, he said. Ultrasound is actually well positionedto withstand and even benefit from changes in physician and capitalequipment reimbursement.
"Ultrasound is one of the least expensive of all (typesof) medical imaging capital equipment. It also tends to be thegreatest revenue producer. If what you want to do is make thehospitals more cost-effective, they can invest less money andgenerate more revenue (with ultrasound)," Maslak said.
A Victory for Radiology: New CMS Proposal Would Provide Coverage of CT Colonography in 2025
July 12th 2024In newly issued proposals addressing changes to coverage for Medicare services in 2025, the Centers for Medicare and Medicaid Services (CMS) announced its intent to provide coverage of computed tomography colonography (CTC) for Medicare beneficiaries in 2025.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
ACR Collaborative Model Leads to 35 Percent Improvement with Mammography Positioning Criteria
July 1st 2024Noting significant variation with facilities for achieving passing criteria for mammography positioning, researchers found that structured interventions, ranging from weekly auditing of images taken by technologists to mechanisms for feedback from radiologists to technologists, led to significant improvements in a multicenter study.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.